Clinical Trial Update: Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compared pemetrexed plus cisplatin versus gemcitabine plus cisplatin in advanced/metastatic non-small cell lung cancer; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer, Efficacy | Phase 2 | Status: COMPLETED | Results posted: 2016-06-16